Trial Profile
Phase I Study Evaluating the Safety of Bevacizumab in Women With a History of Breast Cancer Suffering From Moderate to Severe Upper Extremity Lymphedema
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Lymphoedema
- Focus Adverse reactions
- 22 Oct 2014 New trial record